Serotype distribution and antimicrobial resistance patterns of invasive isolates of Streptococcus pneumoniae: Alaska, 1991-1998

Journal of Infectious Diseases

Volumn 182, Issue 2, 2000, Pages 490-496

  Rudolph, K M ^a   Parkinson, A J ^a   Reasonover, A L ^a   Bulkow, L R ^a   Parks, D J ^a   Butler, J C ^a  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; COTRIMOXAZOLE; ERYTHROMYCIN; PENICILLIN DERIVATIVE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; GEOGRAPHIC DISTRIBUTION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS; STREPTOCOCCUS PNEUMONIAE; UNITED STATES;

ALASKA; BACTERIAL VACCINES; CHILD; CHILD, PRESCHOOL; ERYTHROMYCIN; HUMANS; INDIANS, NORTH AMERICAN; INFANT; PENICILLIN RESISTANCE; PNEUMOCOCCAL INFECTIONS; POLYSACCHARIDES, BACTERIAL; POPULATION SURVEILLANCE; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; TIME FACTORS; TRIMETHOPRIM RESISTANCE; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 0033840366     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315716     Document Type: Article

References (37)

1. The continued emergence of drug-resistant Streptococcus pneumoniae in the United States: An update from the Centers of Disease Control and Prevention's Pneumococcal Sentinal Surveillance System
2. Emergence of drug-resistant pneumococcal infections in the United States
3. Antimicrobial resistance in Streptococcus pneumoniae: An overview
4. Serotype distribution and antimicrobial resistance patterns of invasive isolates of Streptococcus pneumoniae: Alaska 1986-1990
5. The epidemiology of invasive pneumococcal disease in Alaska, 1986-1990: Ethnic differences and opportunities for prevention
6. Streptococcus
7. Antibiotic resistance in Streptococcus pneumoniae
8. Potential interventions for the prevention of childhood pneumonia: Geographic and temporal differences in serotype and serogroup distribution of sterile site pneumococcalisolates from children - Implications for vaccine strategies
9. Epidemiology of pneumococcal serotypes and conjugate vaccine formulations
10. The clinical effectiveness of pneumococcal vaccine in the elderly
11. Pneumococcal polysaccharide vaccine efficacy: An evaluation of current recommendations
12. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine
13. Preventing pneumococcal bacteremia in patients at risk: Results of a matched case-control study
14. Effectiveness of pneumococcal polysaccharide vaccine for preschool-age children with chronic disease
15. Influenza and pneumococcal vaccination levels among adults aged ≥65 years: United States, 1997
16. Safety and immunogenicity of heptavalent pneumococcal CRMl97 conjugate vaccine in infants and toddlers
17. Immunity to cross-reactive serotypes induced by pneumococcal conjugate vaccines in infants
18. Epidemiology and in vitro susceptibility of drug-resistant Streptococcus pneumoniae
19. Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 Results from the SENTRY Antimicrobial Surveillance Program
20. Antibiotic-resistant pneumococcal disease in South African children
21. The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta
22. Evolution of Streptococcus pneumoniae serotypes and antibiotic resistance in Spain: Update (1990 to 1996)
23. Characterization of a multidrug-resistant clone of invasive Streptococcus pneumoniae serotype 6B in Alaska using pulsed-field gel electrophoresis and PspA serotyping
24. Molecular epidemiology of drug-resistant pneumococci: Toward an international approach
25. High prevalence of multidrug-resistant Streptococcus pneumoniae among children in a rural Kentucky community
26. Risk factors for carriage of drug-resistant Streptococcus pneumoniae among children in Memphis, Tennessee
27. Resistant pneumococci: Protecting patients through judicious use of antibiotics
28. An outbreak of pneumonia and bacteremia due to multidrug-resistant Streptococcus pneumoniae among unvaccinated nursing home residents
29. Carriage of multidrug-resistant Streptococcus pneumoniae and impact of chemoprophylaxis during an outbreak of meningitis at a day care center
30. Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians
31. Antibiotic prescribing for children with colds, upper respiratory tract infections, and bronchitis
32. Why do physicians prescribe antibiotics for children with upper respiratory tract refections?
33. Decreasing antibiotic use in ambulatory practice: Impact of a multidimensional intervention on the treatment of uncomplicated acute bronchitis in adults
34. Limiting the spread of penicillin-resistant Streptococcus pneumoniae: Experiences from the South Swedish Pneumococcal Intervention Project
35. The association between antimicrobial drug use in the community and carriage of penicillin non-susceptible Streptococcus pneumoniae
36. Provider and community education decreases antimicrobial use and carriage of penicillin-resistant Streptococcus pneumoniae (PRSP) in rural Alaska communities